AnalystsEd ArceEd Arce's Stock Forecasts
AnalystsEd Arce
Analyst Ranking
Top 2%
#68 out of 5157 analysts
Average Return
+15.98%
Win Rate
46%209 out of 456
Risk vs Reward
Poor
Good
Ed Arce's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +886.15% | $22.39 | $220.80 | 2025-03-09 - 2025-12-19 | Buy |
Cidara Therapeutics IncCDTX | +807.03% | $11.38 | $103.22 | 2024-10-21 - 2025-10-21 | Buy |
Cidara Therapeutics IncCDTX | +677.45% | $13.35 | $103.79 | 2024-11-10 - 2025-11-10 | Buy |
Cymabay Therapeutics IncCBAY | +481.01% | $1.79 | $10.40 | 2022-05-15 - 2023-05-15 | Buy |
Cidara Therapeutics IncCDTX | +467.03% | $11.80 | $66.91 | 2024-09-15 - 2025-09-15 | Buy |
Ed Arce Analyst Color
Get additional color on Ed Arce's coverage of popular stocks
Ed Arce's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Enanta Pharmaceuticals IncENTA | 13 | Strong Buy | $28.00 | +81.94% | Maintains | 3 months ago |
Travere Therapeutics IncTVTX | 21 | Buy | $30.00 | -13.07% | Assumes | 6 months ago |
Metavia IncMTVA | 3 | Buy | $132.00 | +1,431.32% | Reiterates | 8 months ago |
Unicycive Therapeutics IncUNCY | 27 | Buy | $75.00 | +1,248.92% | Reiterates | 8 months ago |
Arcturus Therapeutics Holdings IncARCT | 28 | Buy | $60.00 | +818.84% | Reiterates | 8 months ago |
Akebia Therapeutics IncAKBA | 29 | Buy | $7.50 | +351.81% | Reiterates | 9 months ago |
Inventiva SaIVA | 16 | Buy | $13.00 | +208.79% | Reiterates | 9 months ago |
Talphera IncTLPH | 13 | Buy | $6.00 | +445.45% | Reiterates | 9 months ago |
Aligos Therapeutics IncALGS | 6 | Buy | $70.00 | +555.43% | Reiterates | 9 months ago |
Acurx Pharmaceuticals IncACXP | 17 | Buy | $240.00 | +7,107.21% | Reiterates | 9 months ago |
Sagimet Biosciences IncSGMT | 11 | Buy | $32.00 | +409.55% | Reiterates | 9 months ago |
Cidara Therapeutics IncCDTX | 21 | Buy | $35.00 | -84.15% | Maintains | 9 months ago |
Akero Therapeutics IncAKRO | 23 | Buy | $75.00 | +37.24% | Maintains | 10 months ago |
89bio IncETNB | 22 | Buy | $21.00 | +41.51% | Reiterates | 10 months ago |
Mirum Pharmaceuticals IncMIRM | 30 | Buy | $72.00 | -7.38% | Maintains | 10 months ago |
Madrigal Pharmaceuticals IncMDGL | 15 | Buy | $405.00 | -31.47% | Maintains | 10 months ago |
Ardelyx IncARDX | 9 | Hold | $5.50 | -3.17% | Reiterates | 10 months ago |
Ultragenyx Pharmaceutical IncRARE | 6 | Buy | $95.00 | +183.58% | Reiterates | 10 months ago |
Genfit SaGNFTY | 17 | Buy | $13.00 | +168.04% | Reiterates | 10 months ago |
Arbutus Biopharma CorpABUS | 18 | Buy | $5.00 | +12.87% | Reiterates | a year ago |
Newamsterdam Pharma Co NvNAMS | 2 | Buy | $48.00 | +36.71% | Reiterates | a year ago |
Terns Pharmaceuticals IncTERN | 11 | Hold | $7.50 | N/A | Reiterates | a year ago |
Galectin Therapeutics IncGALT | 10 | Buy | $11.00 | N/A | Reiterates | a year ago |
Pliant Therapeutics IncPLRX | 20 | Buy | $38.00 | N/A | Reiterates | a year ago |
Iterum Therapeutics PLCITRM | 11 | Buy | $5.00 | N/A | Reiterates | a year ago |
Aurinia Pharmaceuticals IncAUPH | 12 | Buy | $13.00 | N/A | Reiterates | a year ago |
Zyversa Therapeutics IncZVSA | 4 | Buy | $240.00 | N/A | Reiterates | 2 years ago |
Cymabay Therapeutics IncCBAY | 13 | Hold | $32.50 | N/A | Reiterates | 2 years ago |
Vera Therapeutics IncVERA | 7 | Buy | $25.00 | N/A | Reiterates | 2 years ago |
Intercept Pharmaceuticals IncICPT | 10 | Hold | $19.00 | N/A | Downgrades | 2 years ago |
Synlogic IncSYBX | 6 | Buy | $75.00 | N/A | Reiterates | 2 years ago |
Durect CorpDRRX | 6 | Buy | $27.00 | N/A | Maintains | 2 years ago |
Paratek Pharmaceuticals IncPRTK | 9 | Hold | $2.15 | N/A | Reiterates | 2 years ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $40.00 | N/A | Reiterates | 2 years ago |
Assembly Biosciences IncASMB | 2 | Hold | $18.00 | N/A | Maintains | 3 years ago |
Albireo Pharma IncALBO | 7 | Hold | $42.00 | N/A | Reiterates | 3 years ago |
Axcella Health IncAXLA | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Mimecast LtdMIME | 1 | Buy | $69.00 | N/A | Maintains | 4 years ago |
Entasis Therapeutics Holdings IncETTX | 3 | Hold | $1.80 | N/A | Downgrades | 4 years ago |
Dicerna Pharmaceuticals IncDRNA | 6 | Hold | $38.25 | N/A | Downgrades | 4 years ago |
Metacrine IncMTCR | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Galmed Pharmaceuticals LtdGLMD | 3 | Buy | $4,500.00 | N/A | Maintains | 5 years ago |
Avenue Therapeutics IncATXI | 2 | Buy | $14,625.00 | N/A | Maintains | 6 years ago |
Trevena IncTRVN | 4 | Buy | $2,187.50 | N/A | Assumes | 7 years ago |
Tetraphase Pharmaceuticals IncTTPH | 2 | Buy | $7.00 | N/A | Maintains | 7 years ago |
Viking Therapeutics IncVKTX | 1 | Buy | $7.00 | N/A | Assumes | 8 years ago |
Ocera Therapeutics IncOCRX | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Collegium Pharmaceutical IncCOLL | 1 | Buy | $21.00 | N/A | Initiates Coverage On | 8 years ago |
Nabriva Therapeutics PLCNBRVF | 2 | Buy | $4,500.00 | N/A | Maintains | 8 years ago |
Atea Pharmaceuticals IncAVIR | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Medicines CoMDCO | 1 | Buy | $57.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.